Background. Despite widespread advocacy for shared decision making (SDM), the empirical evidence regarding its effectiveness to improve patient outcomes has not been systematically reviewed. The purpose of this study was to systematically review the empirical evidence linking patient outcomes and SDM, when the decision-making process has been explicitly measured, and to identify under what measurement perspectives SDM is associated with which types of patient outcomes (affective-cognitive, behavioral, and health). Data Sources. PubMed (through December 2012) and hand search of article bibliographies. Study Selection. Studies were included if they empirically 1) measured SDM in the context of a patient-clinician interaction and 2) evaluated the relationship between SDM and at least 1 patient outcome. Data Extraction. Study results were categorized by SDM measurement perspective (patient-reported, clinician-reported, or observer-rated) and outcome type (affective-cognitive, behavioral, or health). Data Synthesis. Thirty-nine studies met inclusion criteria. Thirty-three used patient-reported measures of SDM, 6 used observer-rated measures, and 2 used clinician-reported measures. Ninety-seven unique patient outcomes were assessed; 51% affective-cognitive, 28%
Background. Despite widespread advocacy for shared decision making (SDM), the empirical evidence regarding its effectiveness to improve patient outcomes has not been systematically reviewed. The purpose of this study was to systematically review the empirical evidence linking patient outcomes and SDM, when the decision-making process has been explicitly measured, and to identify under what measurement perspectives SDM is associated with which types of patient outcomes (affective-cognitive, behavioral, and health). Data Sources. PubMed (through December 2012) and hand search of article bibliographies. Study Selection. Studies were included if they empirically 1) measured SDM in the context of a patient-clinician interaction and 2) evaluated the relationship between SDM and at least 1 patient outcome. Data Extraction. Study results were categorized by SDM measurement perspective (patient-reported, clinician-reported, or observer-rated) and outcome type (affective-cognitive, behavioral, or health). Data Synthesis. Thirty-nine studies met inclusion criteria. Thirty-three used patient-reported measures of SDM, 6 used observer-rated measures, and 2 used clinician-reported measures. Ninety-seven unique patient outcomes were assessed; 51% affective-cognitive, 28% behavioral, and 21% health. Only 43% of assessments (n = 42) found a significant and positive relationship between SDM and the patient outcome. This proportion varied by SDM measurement perspective and outcome category. It was found that 52% of outcomes assessed with patient-reported SDM were significant and positive, compared with 21% with observer-rated and 0% with clinician-reported SDM. Regardless of measurement perspective, SDM was most likely to be associated with affective-cognitive patient outcomes (54%), compared with 37% of behavioral and 25% of health outcomes. Limitations. The relatively small number of studies precludes meta-analysis. Because the study inclusion and exclusion criteria required both an empirical measure of SDM and an assessment of the association between that measure and a patient outcome, most included studies were observational in design. Conclusions. SDM, when perceived by patients as occurring, tends to result in improved affective-cognitive outcomes. Evidence is lacking for the association between empirical measures of SDM and patient behavioral and health outcomes. Keywords: shared decision making; medical decision making; patient outcomes; systematic review. (Med Decis Making 2015; 35:114-131) Additionally, many evaluations of SDM interventions cite the possible benefits of SDM on patient outcomes as a justification for the study (e.g., Hamann and others 13 ; Wilkins and others 14 ; Légaré and others 15 ). Furthermore, models have been developed that specifically hypothesize the way that SDM and other patient-provider communication may affect health-related patient outcomes. 16, 17 Thus, although the aim of SDM has not always been to improve patient health outcomes, it is valuable to systematically evaluate the empirical evidence supporting the impact of SDM on a range of patient outcomes.
Previous systematic reviews have pointed to the effectiveness of decision aids for improving patient outcomes, 18 but as evidenced by these reviews, use of a decision aid does not ensure that SDM occurs. For example, in the most recent Cochrane review of decision aids (2011), only 16 of the 86 randomized trials reviewed explicitly measured the effects of decision aids on patient participation in decision making. Among these studies, there were no differences in patient reports of having participated in SDM between those given a decision aid or those receiving usual care. 18 Thus, the positive effects of decision aids on patient outcomes may not be attributable to SDM. Moreover, the empirical evidence surrounding SDM is not confined to studies of decision aids only.
Despite widespread advocacy for SDM and a growing body of literature evaluating its use, the empirical evidence regarding its effectiveness as a mechanism to improve patient outcomes has not been systematically summarized. Additionally, SDM has been measured in a variety of ways across studies, and these measurement perspectives may represent different perceptions about the meaning of SDM. Given the current lack of synthesis of the literature, whether these different measurement perspectives are differentially associated with patient outcomes is not known. The objectives of this systematic review are twofold. The first is to describe the patient outcomes that have been studied in relation to SDM, when the decision-making process has been explicitly measured with an SDM measurement tool and the relationship between that measure of SDM and at least 1 patient outcome was evaluated. The second objective is to identify under what measurement perspectives (patient-reported, clinician-reported, or observer-rated) SDM is associated with which types of patient outcomes.
METHODS

Conceptual Framework
The conceptual framework guiding this systematic review was adapted from models by Street and colleagues 16 and Kreps and colleagues 17 (Figure 1 ). In their model of pathways in which clinician-patient communication can lead to better health, Street and colleagues posited that while communication between clinicians and patients, including SDM, can lead to improved health outcomes directly, in most cases communication affects health indirectly through proximal and intermediate outcomes. As proposed by Kreps and colleagues 17 in their Transformation Model of Communication and Health Outcomes, we changed the categorization of outcomes from a temporal classification to a conceptual classification. This latter model asserts that patient outcomes should be categorized by their impact on the individual across 3 categories: affective-cognitive, behavioral, and physiological. Affective-cognitive outcomes include knowledge, attitudinal, and affective-emotional effects. Behavioral outcomes include both adherence to recommended treatments and adoption of health behaviors. Physiological outcomes (which we have broadened to label as ''health outcomes'') include measures quality of life, selfrated health, and biological measures of health (e.g., blood pressure). 17 
Inclusion and Exclusion Criteria
Studies were included in this review if they empirically 1) measured the decision-making process with an SDM measurement tool in the context of a patientclinician interaction and 2) evaluated the relationship between SDM and at least 1 explicitly measured patient outcome. Excluded studies were those that reported only qualitative data or were reviews or commentaries. Also excluded were studies that did not explicitly measure both the decision-making process using an SDM measure and at least 1 patient outcome as well as those that did not quantitatively model the relationship between measured SDM at least 1 patient outcome.
Search Strategy
We began with the primary search strategy outlined by Makoul and Clayman 19 in their 2006 systematic review of the SDM literature. Specifically, in January 2013, we conducted a PubMed search for English-language articles published through December 31, 2012, with the words shared decision making in the title or abstract. Makoul and Clayman reasoned that this search strategy captured articles with a clear focus on SDM in the medical literature and that the simple approach allows for reproducibility for future studies. Due to the lack of agreement across studies regarding how to best define, and thus measure, the occurrence of SDM, we opted to include all studies that explicitly measured SDM, regardless of the tool used. In so doing, we did not prescribe an operational definition of SDM per se but rather assessed all studies that specifically mentioned ''shared decision making'' in the abstract. No start date was specified, so that all studies published up through the end of 2012 would be included. One reviewer (L.A.S.) screened the resulting abstracts for the inclusion and exclusion criteria. The full text of all potentially eligible articles was read and reviewed, and any nonredundant references to SDM were collected. A second reviewer (J.E.L.) reviewed any articles for which eligibility was not clear, and a final inclusion-exclusion decision was made by consensus. Because a number of study-eligible articles evaluated more than 1 patient outcome in relation to SDM, the unit of analysis for this review is a patient outcome.
Classification Framework
There are multiple ways that SDM can be measured. 19, 20 A priori, we expected the measurement of SDM to fall into 2 primary categories: patient self-reports of SDM or observer ratings of the use of SDM (usually via structured coding of audio-recordings). Our review of the literature also revealed a third category: clinician reports of using SDM with patients. In addition to considering the SDM measurement perspective, as indicated in the conceptual framework ( Figure 1 ), we considered the type of outcome evaluated. Because a diversity of outcomes have been assessed in association with SDM, it is helpful to categorize these outcomes to provide for more meaningful discussion of results across studies. Thus, we used an adaptation of the 3 classifications proposed in the Transformation Model of Communication and Health Outcomes 17 : affective-cognitive, behavioral, SHAY AND ELSTON LAFATA and health outcomes. Combined, these categorizations resulted in a 3 3 3 classification framework that was used to structure the results of the systematic review ( Figure 2 ).
Assessment of the Quality of Studies
We used a modified version of the Systematic Appraisal of Quality in Observational Research (SAQOR) tool to assess the quality of included studies. 21 SAQOR was created for use in systematic reviews to assess the quality of observational studies. Each study was rated as adequate, inadequate, or unclear across 6 categories: sample, research design, quality of measures, follow-up, distorting influences (confounders), and reporting of data. A total score for each study is computed by counting the number of categories marked adequate. Thus, the total quality score has a range of 0-6, with higher scores indicating higher quality studies. Total scores of 5 or 6 represent highquality observational studies, scores of 3 or 4 represent moderate-quality observational studies, and scores of 0, 1, or 2 represent low-quality observational studies. 22 After training together on 3 studies, 2 reviewers independently rated each remaining study according to the above criteria. Cohen's kappa was calculated as a measure of interrater reliability of quality ratings at the category level for each study. Interrater reliability of the independent rating of quality scores was high (Cohen's kappa = 0.7). Any discrepancies in scoring were discussed until consensus was reached.
The results of our review are presented below in accordance with the Institute of Medicine's standards for reporting reviews. 23 
RESULTS
Overview of Studies
Forty-one publications representing 39 unique studies met the inclusion criteria ( Figure 3 , Table 1 ). Thirty-four of the 41 articles meeting inclusion criteria were published in the last 10 years, and the earliest study meeting the inclusion criteria was published in 1989 (Brody and others 24 ).
The 39 studies were conducted across a variety of clinical contexts. Fourteen studies (36%) were conducted in the context of cancer care, and almost three-quarters of these (n = 10) focused specifically on breast cancer treatment and surgery decisions. Other clinical contexts studied included mental health (n = 5), diabetes (n = 5), serious injury (n = 3), heart disease (n = 2), HIV (n = 2), and general primary care (n = 2) among others (n = 6).
Quality Assessment
The SAQOR quality scores ranged from 2 to 6, with a median score of 4 ( Table 1) . Across the 39 studies, 3 (8%) received a high quality rating, 30 (77%) moderate, and 6 (15%) low. Most of the studies were either a cross-sectional or prospective survey in which data were collected either before and after, or only after, a consultation with a clinician. Only 9 of the studies used a pretest-posttest design, 24, 27, 39, 40, 42, 44, [60] [61] [62] and 19 studies measured SDM at the same time as measuring the outcome of interest. 25, 26, 28, 29, [31] [32] [33] [34] 37, 41, [45] [46] [47] [49] [50] [51] [52] [53] Nine of the 39 studies were conducted in the context of a clinical trial. 27, 32, 38, 39, 42, 44, 46, 51, 56 Eight of these were a secondary analysis of a previous randomized controlled trial (RCT). 27, 32, 38, 39, 42, 46, 51, 56 In these studies, either the analysis was conducted without regard to group assignment, 51, 56 group assignment was used as a predictor variable in the model, 32, 38, 42, 46 or the results were tested separately to see whether group assignment confounded the relationship between measured SDM and patient outcomes. 27, 39 The ninth study included a patient self-report of participation in SDM but only tested the association of patient-reported SDM with a patient outcome among those in the experimental group. 44 Thus, none of the included RCTs evaluated the association between SDM and a patient outcome with a randomized design.
SDM Measurement Perspective
Eighty-five percent of studies measured SDM from the patient's perspective (n = 33), 15% (n = 6) measured via observer rating, and 2 (8%) used clinician-reports to measure SDM. In 2 studies, 48,55 the same patient outcome was assessed for its association with SDM from different SDM measurement perspectives, and these analyses are considered separately. (text continues on p. 124) concern regarding illness; satisfaction with the physician; experiencing discomfort; experiencing dysfunction; symptom improvement; general medical improvement SDM associated with greater sense of personal control, lower postvisit levels of concern regarding illness, less discomfort, greater symptom improvement, and greater improvements in overall medical condition 1 week after visit.
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No association between SDM and experiencing dysfunction 1 week after visit. current breast cancer concern; current depressive symptoms SDM (v. patient-controlled decisions) associated with lower satisfaction 6 months after surgery and lower current concern about breast cancer.
No associations between SDM and current satisfaction or current depressive symptoms. e. Two studies measured SDM from multiple perspectives. Each unique SDM measurement and patient outcome assessment is listed separately here and throughout the review. f. Johnson and others 51 report the results from 2 separate studies in 1 publication. Each study is listed separately here and throughout the review.
Patient-reported SDM was measured in a variety of ways across studies. The most commonly used measure was a modified version of the Control Preference Scale 65 in which patients rate their perceptions about their level of involvement in decision making (n = 13 studies). In its original form, the Control Preference Scale measures an individual's preferences for his or her role in decision making, and it has been validated across several different patient and clinical contexts and shown to have good reliability. 66, 67 The second most commonly used patient-reported measure of SDM was the multi-item Patient Involvement in Care Scale, 25 which was used in 4 studies. The Patient Involvement in Care Scale has been validated across a number of studies, most commonly in the context of cancer care. 66, 67 A variety of other single and multi-item measures of SDM were used (n = 16 studies), including 5 studies that developed new measures of SDM for their study.
Five of the 6 studies that included observer ratings of SDM used the OPTION scale, in which observers rate the communication between patient and clinician on 12 items. 68 The OPTION scale either is completed by an in-person observer in real time or is used to rate audio-recordings of patient-clinician interactions.
Clinician-reported SDM was used in 2 studies, both in the context of diabetes. 55, 58 One of these used a modified version of the Control Preference Scale 65 and the other used a 9-item Self-Assessment Questionnaire. 69 
Patient Outcomes Evaluated
The number of patient outcomes evaluated per study ranged from 1 to 7, with a total of 95 unique patient outcomes and 97 unique patient outcome-SDM measurement pairs assessed across the 39 studies ( Table 2 ). Among the 97 outcome assessments, 51% (n = 50) were affective-cognitive outcome assessments, 28% (n = 27) behavioral outcome assessments, and 21% (n = 20) health outcome assessments. Half of the affective-cognitive variables studied were related to patient satisfaction (n = 25). Beyond satisfaction, affective-cognitive variables included concerns and anxieties about the illness (n = 5), decisional conflict (n = 4), anxiety following the consultation (n = 4), confidence in the decision (n = 2), and knowledge (n = 2), among others. The most frequent behavioral variable assessed concerned the treatment decision itself (n = 10), with 9 of these regarding breast cancer treatment decisions. Other behavioral variables include treatment and medication adherence (n = 7), health behaviors (n = 3), and others. Health outcomes included patient ratings of overall health (n = 6) and quality of life (n = 3), depressive symptoms (n = 5), and other patient-reported measures (n = 2), as well as a blood pressure (n = 2) and other physiological measures (n = 2).
Associations between SDM and Patient Outcomes
As can be seen in Table 3 , fewer than half (n = 42; 43%) of assessments revealed a statistically significant and positive relationship between SDM and the patient outcome. Results varied by both the SDM measurement perspective and the category of patient outcome. When SDM was measured from the perspective of the patient, regardless of the outcome category, assessments were more likely to result in significant associations. Across all outcomes assessed, 52% were significantly and positively associated with patient-reported SDM, compared with only 21% of outcomes when SDM was observer-rated and 0% when SDM was clinician reported.
Similarly, regardless of how SDM was measured, affective-cognitive patient outcomes were most likely to be associated with SDM. Because a full half of the affective-cognitive outcomes were patient satisfaction variables, we compared the results and conclusions between satisfaction outcomes and those using other affective-cognitive outcomes (online Appendix Table A1 ). As neither the results nor conclusions were altered, we continue to categorize the outcome variables according to our original categorization framework throughout the remainder of the review. In total, 54% of affective-cognitive outcomes were positively associated with SDM, compared with 37% of behavioral and 25% of health patient outcomes. Three studies found negative effects of SDM on patient outcomes including an increase in decisional conflict, 32 a decrease in patient satisfaction, 37 and an increase in patient reports of the impact of breast cancer on their life. 41 All 3 were affective-cognitive patient outcomes in the context of patient selfreports of SDM.
All 5 health outcomes that were found to be associated with SDM were patient self-reported outcomes, including 1-item ratings of general health rating, 46 discomfort, 24 symptom improvement, 24 general medical improvement, 24 and measure of depressive symptoms rated on the Center for Epidemiologic Studies-Depression scale. 39 Among these, only depressive symptoms were measured using a multiitem, previously validated scale. 39 None of the 4 SHAY AND ELSTON LAFATA physiological measures assessed were associated with SDM. 44, 58 
DISCUSSION
Relatively few evaluations have been conducted between SDM and patient outcomes when both the decision-making process and patient outcome have been empirically measured. We found a total of 39 unique studies, which included 97 assessments of the relationship between an empirical measure of SDM and a subsequent empirical measure of a patient outcome. Affective-cognitive outcomes were assessed most often and were primarily patient reports of satisfaction, decisional conflict, or other perceptions immediately after an interaction with a clinician. Furthermore, relative to behavioral and health outcomes, affective-cognitive outcomes were most often found to be significantly and positively associated with SDM. While affective-cognitive outcomes are important and represent SDM's origins as an ethical call to increase patient autonomy, 3, 8 there has been a shift toward understanding how patientclinician communication, including SDM, may be associated with more distal behavioral and health outcomes. 12, 16, 70 Although there are strong ethical and interpersonal reasons to advocate for SDM, our findings illustrate the continued uncertainty surrounding SDM as a mechanism to improve patient outcomes.
Regardless of the type of patient outcome considered or the SDM measurement used, empirical evaluations that have included an explicit measure of the shared decision-making process and a patient outcome more often than not have found no positive and statistically significant relationship between SDM and the patient outcome. The one exception is among assessments that evaluated an affective-cognitive patient outcome in relation to patient-reported SDM. Within these assessments, the majority (66%) found a significant and positive relationship between SDM and a subsequent patient outcome. Notably lacking were any studies that evaluated the association between observer-rated SDM and patient health outcomes. Clinician reports of SDM were also rare, with the 8 such associations evaluated here coming from only 2 independent studies, with none found to have a significant association with a patient outcome.
Notably, 85% of the studies identified for review measured SDM via a patient self-report. As previously reported, 19, 20 within the patient-reported SDM measurement category, a wide range of measures of patient perceptions of SDM are currently being used. While variations of the Control Preference Scale 65 are most commonly used, we found 16 different instruments used across the 33 studies that measured SDM via patient self-report. Regardless of whether the Control Preference Scale or some other instrument is used to capture patient-reported use of SDM, more often than not the items contained in 
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REVIEW these instruments do not reveal what it is about the decision-making process that leads a patient to report that it was shared. Additionally, many of the patientreported measures of SDM used were not previously validated or were not validated for the population for which they were being used. Taken together, these observations are particularly troubling as several recent studies have found that observer ratings of SDM do not predict patient reports of having participated in a shared decision. 48, 66, 67 These findings may represent differences in conceptual definitions of SDM or may highlight problems with the current tools for measuring SDM. Regardless, these results (combined with our findings that when positively associated with a patient outcome, it is patient-perceived SDM and not observer-rated SDM that is important) highlight the importance of understanding the patient's perspective as critical to the Total measured 97 a. Positive refers to a significant, positive (i.e., beneficial) association between SDM and the patient outcome. NS refers to a nonsignificant association. Negative refers to a significant, negative (i.e., nonbeneficial) association between SDM and the patient outcome. science of measuring SDM. As better tools are developed to measure SDM, it will be critical understand what leads a patient to label a decision as ''shared.'' Without such an understanding, our ability to foster SDM processes in practice will continue to be hindered as will our ability to fully understand the impact of SDM on patient outcomes. Our review highlights several important points regarding the assessment of SDM and patient health outcomes. First, health outcomes were least studied. Second, when health outcomes have been assessed in relation to SDM, the outcomes have most often been measured via patient self-report and often with unvalidated instruments. In total, only 5 of the 20 (25%) health outcomes evaluated were found to be associated with SDM, and 4 of these used single-item unvalidated measures. Furthermore, we identified only 4 physiological measures of patient health (blood pressure, hemoglobin A1c, and lipid level) that have been evaluated for their association with SDM, and none of these evaluations identified a statistically significant relationship. 44, 58 Results from this review thus indicate that the link between SDM and health patient outcomes, in particular, has yet to be fully established.
SHAY AND ELSTON LAFATA
Notably lacking among the SDM literature are randomized trials evaluating the impact of a communication/decision-making intervention on patient outcomes that empirically measure the communication/decision-making process used. Many RCTs in recent years have evaluated the effects of some type of communication or decision-making intervention on patient outcomes. These interventions most often center on a decision aid but also include patient or clinician communication training interventions. 71, 72 Decision aid studies, in particular, have shown decision aids to be effective at improving patient outcomes. 18 However, many of these intervention studies have not included an empirical measure of SDM, instead assuming SDM to have occurred based on group assignment, or they have included a measure of SDM as means of quality control but have not modeled the empirical measure of SDM with patient outcomes. Without an evaluation of the empirical measure of SDM with patient outcomes, it is not clear that SDM (or something else) is what led to an improvement in the patient outcome. The Cochrane review's finding that there were no differences in patient self-reports of SDM by group assignment among decision aid studies that included an empirical measure of SDM highlights the uncertainty of what led to the changes in patient outcomes. 19 Our review identified only 9 studies conducted in the context of a randomized trial, 27, 32, 38, 39, 42, 44, 46, 51, 56 and despite the design of the parent study, none reported the association of SDM and a patient outcome in the context of the randomized design.
Until now, SDM has almost always been measured cross-sectionally in the context of one interaction or discussion. This may explain, in part, the general lack of association between SDM and patient outcomes. That is, one discussion between a clinician and patient may not lead to improved health outcomes. Instead, a long-standing relationship between a clinician and patient marked by patient-centered care and SDM may affect outcomes over time. To complement thoughtful conceptual models that hypothesize the paths between patient and clinician communication behaviors and patient outcomes (e.g., Street and others 16 ), well-designed studies are needed that measure multiple patient and physician interactions and patient outcomes over time to formally test whether decision-making and communication interventions lead to increased SDM, and then whether it is these increases in SDM (or something else) that are associated with health outcomes. SDM may mediate or even moderate the relationship between communication or decision-making interventions and patient outcomes. For example, SDM may improve patient satisfaction, which over time may lead to trust in the physician, followed by adherence to physician recommendations and ultimately improved health. 73 However, these relationships remain largely untested in the empirical literature.
In the meantime, SDM may be better advocated on ethical grounds. Patient-centered care, including SDM, is important outside of its potential effect on patient health outcomes. The US Preventive Task Force highlighted the multiple perspectives on which SDM can be recommended. These included an ethical mandate to protect patient autonomy and self-determination, an interpersonal benefit of promoting trust in the patient-clinician relationship, and an educational gain of increasing patient knowledge about treatment options, benefits, and harms through an SDM process. 5 Thus, despite only limited evidence that SDM improves patient outcomes, there are still important reasons to advocate for an SDM process when making healthcare decisions.
Limitations
Our conceptual framework examines the impact of SDM when explicitly measured on patient outcomes across 2 important domains-the perspective from which SDM was measured and the type of patient SHAY AND ELSTON LAFATA outcome. However, undoubtedly there are other dimensions that are important to understanding the relationship between SDM and patient outcomes. For example, the clinical context in which the decision was made and the nature of the decision itself (prevention v. acute treatment v. chronic treatment decisions, etc.) may influence the impact of SDM on patient outcomes. Given the relatively small number of studies identified as eligible for study inclusion, we were not able to further categorize studies for this first systematic review.
We recognize that SDM (particularly patient perceptions of SDM) may not be limited to the context of one visit between a patient and clinician, but rather patient reports of SDM may be influenced by the prior relationship between the patient and clinician or by the influence of other parties in the decision. 66 This is especially likely to be true in primary care and chronic disease contexts in which patients and their clinicians often make multiple decisions over the course of many visits. However, none of the studies identified here measured SDM across a long-standing relationship, and thus we are unable to discuss how SDM may affect patient outcomes over time. Additionally, all of the studies reviewed here examined SDM in the context of a patient and clinician only, limiting our ability to examine the effects of having family members or others participate in decision making.
The study inclusion and exclusion criteria may have also affected our findings. Our aim in the current review was to understand how SDM is currently measured and how SDM using these different measures is (or is not) associated with various patient outcomes. As such, the study inclusion criteria required both an empirical measure of SDM and an assessment of the association between that measure and a patient outcome. Based on these criteria, most of the included studies were observational studies rather than randomized clinical trials, as most intervention studies did not include an evaluation of the association of an empirical measure of SDM and patient outcomes. Rather, if the investigators in those studies chose to draw conclusions specific to SDM, they did so by evaluating the effect of intervention group assignment on patient outcomes. Thus, there may be additional patient outcomes that have been assessed in relationship to an SDM intervention that are not discussed in this review. Our findings are also limited by the psychometric properties of both the SDM and outcome measures used in the studies meeting our inclusion criteria. Although we cannot formally assess the impact of such measurement limitations on our findings, it is important to acknowledge that the psychometric properties of both the SDM and outcome measures were varied or, at times, not reported.
Finally, the results and conclusions presented here may be influenced by publication biases. Although we were careful to review articles identified as eligible for inclusion for additional nonredundant references, we did not attempt to identify and include results from unpublished studies. Additionally, due to the diversity of patient outcomes assessed across studies combined with the relative paucity of studies, we were not able to use meta-analysis methods. As consensus is built around the measurement of SDM and the patient outcomes most salient to SDM, future systematic reviews may be able to use a metaanalysis to formally combine and assess the evidence across studies.
CONCLUSION
Our review suggests that when patients report that they have participated in SDM, they are likely to enjoy better affective-cognitive outcomes, such as improved satisfaction and less decisional conflict. Furthermore, patient reports are the only SDM measurement perspective found to be associated with patient health outcomes, albeit in a minority of those studies. The challenge with these findings is that we do not know what leads a patient to report a decision as shared and, thus, we do not know how to foster SDM and its associated benefits in practice. Thus, not only should future studies continue to address the impact of SDM across a continuum of patient outcomes and clinical settings, but they should also address the methodological challenges associated with such evaluations, including how best to measure SDM. Patients increasingly report a desire to engage in SDM, and SDM remains an important tool to promote patient autonomy and satisfaction. However, our findings indicate that with the measures of SDM currently available, the link between SDM and patient behavioral and health outcomes has yet to be fully established.
